Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04821128
Other study ID # 242
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date November 27, 2020
Est. completion date May 27, 2021

Study information

Verified date March 2021
Source Hospices Civils de Lyon
Contact Leonard MEGUERDITCHIAN, MD
Phone 6 10 46 17 70
Email leonard.meguerditchian-hoffmeyer@chu-lyon.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim of the study is to assess the good correlation and prediction of the DOI for the post-operative pathological results and prognosis.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date May 27, 2021
Est. primary completion date November 27, 2020
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - patients chirurgically treated for an OSCC - T1 T2 T3 - CT scanner in their medical file Exclusion Criteria: - T4 - R+ résection - Artefacts on CT scanner

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Radiologic and pathological review.
We will analyse the pre operative scannographic and MRI (if available) images, and the post operative pathological analyses. The scanners will be reviewed by 2 well trained clinicians (one head and neck radiologist and one head and neck surgeon). Then we will analyse the correlation between the radiological and the pathological analysis.

Locations

Country Name City State
France Croix rousse hospital Lyon

Sponsors (1)

Lead Sponsor Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary The primary outcome will be the measure of the correlation of the depth of invasion on the radiological pre operative images and of the pathological analyses on the resection piece. With a Bland Altman analysis we will assess the good correlation between the pre and post operatory mesures of the depth of invasion in the oral squamous cell carcioma The outcome will be measured at the inclusion of the patient in the current study.
See also
  Status Clinical Trial Phase
Recruiting NCT06112522 - Tirbanubulin (Klisiry®) in the Treatment of Basal Cell Carcinoma Phase 2
Recruiting NCT05623748 - Establishment and Application of 3-Dimensional (3-D) Cell Culture Model of Clinical Circulating Tumor Cells (CTCs)